184 related articles for article (PubMed ID: 22450906)
1. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
Ito I; Ito Y; Mizuno M; Suzuki Y; Yasuda K; Ozaki T; Kosugi T; Yasuda Y; Sato W; Tsuboi N; Maruyama S; Imai E; Matsuo S
Clin Exp Nephrol; 2012 Jun; 16(3):490-4. PubMed ID: 22450906
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
Ogura T; Tajika M; Niwa Y; Kawai H; Kondo S; Sawaki A; Mizuno N; Hara K; Hijioka S; Nakamura M; Higuchi K; Goto H; Yamao K
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1712-9. PubMed ID: 21971145
[TBL] [Abstract][Full Text] [Related]
3. Acute renal failure related to oxaliplatin-induced intravascular hemolysis.
Ulusakarya A; Misra S; Haydar M; Habert H; Castagne V; Gumus Y; Delmas-Marsalet B; Machover D
Med Oncol; 2010 Dec; 27(4):1425-6. PubMed ID: 19565364
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
5. An immediate hemolytic reaction induced by repeated administration of oxaliplatin.
Chen VM; Thrift KM; Morel-Kopp MC; Jackson D; Ward CM; Flower RL
Transfusion; 2004 Jun; 44(6):838-43. PubMed ID: 15157248
[TBL] [Abstract][Full Text] [Related]
6. Disseminated intravascular coagulation and immune hemolytic anemia, possibly Evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review.
Meng L; Romano A; Smith E; Macik G; Grosh WW
Clin Colorectal Cancer; 2015 Mar; 14(1):e1-3. PubMed ID: 25600448
[No Abstract] [Full Text] [Related]
7. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.
Lubner SJ; Loconte NK; Holen KD; Schelman W; Thomas JP; Jumonville A; Eickhoff JC; Seo S; Mulkerin DL
Clin Colorectal Cancer; 2010 Jul; 9(3):157-61. PubMed ID: 20643620
[TBL] [Abstract][Full Text] [Related]
9. Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy.
Leonard GD; Wagner MR; Quinn MG; Grem JL
Anticancer Drugs; 2004 Aug; 15(7):733-5. PubMed ID: 15269607
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-mediated autoimmune thrombocytopenia.
Saif MW; The A; Ledbetter L
Clin Colorectal Cancer; 2009 Jan; 8(1):61-2. PubMed ID: 19203900
[No Abstract] [Full Text] [Related]
11. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
Malkhasyan K; Halene S; Lacy J
Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
[No Abstract] [Full Text] [Related]
12. [Immune-mediated hemolytic anemia under oxaliplatin].
Gundling F; Tiller M; Fuchs M; Schepp W
Z Gastroenterol; 2008 Jul; 46(7):695-9. PubMed ID: 18618381
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.
Rothenberg ML; Cox JV; Butts C; Navarro M; Bang YJ; Goel R; Gollins S; Siu LL; Laguerre S; Cunningham D
Ann Oncol; 2008 Oct; 19(10):1720-6. PubMed ID: 18550577
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-induced immune pancytopenia.
Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
[TBL] [Abstract][Full Text] [Related]
15. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
16. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
Shao YY; Hong RL
Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Sørbye H; Bruserud Y; Dahl O
Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
[No Abstract] [Full Text] [Related]
18. Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran.
Shahriari-Ahmadi A; Fahimi A; Payandeh M; Sadeghi M
Asian Pac J Cancer Prev; 2015; 16(17):7603-6. PubMed ID: 26625769
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
Seymour MT; Thompson LC; Wasan HS; Middleton G; Brewster AE; Shepherd SF; O'Mahony MS; Maughan TS; Parmar M; Langley RE; ;
Lancet; 2011 May; 377(9779):1749-59. PubMed ID: 21570111
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer.
Zeuli M; Nardoni C; Pino MS; Gamucci T; Gabriele A; Ferraresi V; Giannarelli D; Cognetti F
Ann Oncol; 2003 Sep; 14(9):1378-82. PubMed ID: 12954576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
